rs10814431

Positions:

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_203447.4(DOCK8):​c.2340G>C​(p.Leu780=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.245 in 1,610,908 control chromosomes in the GnomAD database, including 49,661 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4817 hom., cov: 33)
Exomes 𝑓: 0.24 ( 44844 hom. )

Consequence

DOCK8
NM_203447.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.298
Variant links:
Genes affected
DOCK8 (HGNC:19191): (dedicator of cytokinesis 8) This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 9-377111-G-C is Benign according to our data. Variant chr9-377111-G-C is described in ClinVar as [Benign]. Clinvar id is 137139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-377111-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.298 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DOCK8NM_203447.4 linkuse as main transcriptc.2340G>C p.Leu780= synonymous_variant 20/48 ENST00000432829.7 NP_982272.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DOCK8ENST00000432829.7 linkuse as main transcriptc.2340G>C p.Leu780= synonymous_variant 20/481 NM_203447.4 ENSP00000394888 Q8NF50-1

Frequencies

GnomAD3 genomes
AF:
0.247
AC:
37504
AN:
152070
Hom.:
4812
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.330
Gnomad AMR
AF:
0.234
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.0733
Gnomad SAS
AF:
0.258
Gnomad FIN
AF:
0.181
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.256
GnomAD3 exomes
AF:
0.225
AC:
55806
AN:
247598
Hom.:
6724
AF XY:
0.229
AC XY:
30746
AN XY:
134058
show subpopulations
Gnomad AFR exome
AF:
0.284
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.0639
Gnomad SAS exome
AF:
0.263
Gnomad FIN exome
AF:
0.185
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.234
GnomAD4 exome
AF:
0.245
AC:
356785
AN:
1458722
Hom.:
44844
Cov.:
36
AF XY:
0.245
AC XY:
178104
AN XY:
725640
show subpopulations
Gnomad4 AFR exome
AF:
0.281
Gnomad4 AMR exome
AF:
0.205
Gnomad4 ASJ exome
AF:
0.205
Gnomad4 EAS exome
AF:
0.0778
Gnomad4 SAS exome
AF:
0.262
Gnomad4 FIN exome
AF:
0.184
Gnomad4 NFE exome
AF:
0.253
Gnomad4 OTH exome
AF:
0.246
GnomAD4 genome
AF:
0.247
AC:
37522
AN:
152186
Hom.:
4817
Cov.:
33
AF XY:
0.241
AC XY:
17954
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.284
Gnomad4 AMR
AF:
0.234
Gnomad4 ASJ
AF:
0.193
Gnomad4 EAS
AF:
0.0734
Gnomad4 SAS
AF:
0.259
Gnomad4 FIN
AF:
0.181
Gnomad4 NFE
AF:
0.250
Gnomad4 OTH
AF:
0.253
Alfa
AF:
0.243
Hom.:
940
Bravo
AF:
0.250
Asia WGS
AF:
0.164
AC:
571
AN:
3478
EpiCase
AF:
0.251
EpiControl
AF:
0.259

ClinVar

Significance: Benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 42% of patients studied by a panel of primary immunodeficiencies. Number of patients: 40. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 27, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Leu780Leu in exon 20 of DOCK8: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 28.8% (1271/4406) o f African American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs10814431). -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:1Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Autosomal recessive hyper-IgE syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Combined immunodeficiency due to DOCK8 deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
3.3
DANN
Benign
0.74
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10814431; hg19: chr9-377111; COSMIC: COSV66618101; API